EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 262 filers reported holding EDITAS MEDICINE INC in Q3 2022. The put-call ratio across all filers is 0.79 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $109,475 | -29.9% | 15,100 | -14.2% | 0.00% | -50.0% |
Q4 2022 | $156,112 | -0.4% | 17,600 | +37.5% | 0.00% | 0.0% |
Q3 2022 | $156,672 | -37.1% | 12,800 | -2.3% | 0.00% | 0.0% |
Q1 2022 | $249,000 | -44.2% | 13,100 | -22.0% | 0.00% | -33.3% |
Q4 2021 | $446,000 | -35.4% | 16,800 | 0.0% | 0.00% | -57.1% |
Q3 2021 | $690,000 | -27.1% | 16,800 | +0.6% | 0.01% | -22.2% |
Q2 2021 | $946,000 | +17.4% | 16,700 | -13.0% | 0.01% | +12.5% |
Q1 2021 | $806,000 | -34.3% | 19,200 | +9.7% | 0.01% | -38.5% |
Q4 2020 | $1,227,000 | +151.4% | 17,500 | +0.6% | 0.01% | +116.7% |
Q3 2020 | $488,000 | – | 17,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |